Kymera Therapeutics, Inc.
KYMR
Kedudukan dalam Saham
#2299
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Harga Saham
$105.36
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$8.67B
Perubahan (1 hari)
-2.57%
Perubahan (1 tahun)
76.10%
Negara
US
Perdagangan Kymera Therapeutics, Inc. (KYMR)
Kategori
Healthcare
EPS untuk Kymera Therapeutics, Inc. (KYMR)
EPS setakat June 2026 TTM: $-3.25
Menurut laporan kewangan terkini dan harga saham Kymera Therapeutics, Inc., EPS semasa syarikat (TTM) adalah $-3.25. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-2.52 penurunan berbanding EPS tahun 2022 iaitu $-2.87.
Sejarah EPS untuk Kymera Therapeutics, Inc. dari 2018 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-3.25 | 9.06% |
| 2024 | $-2.98 | 18.25% |
| 2023 | $-2.52 | -12.20% |
| 2022 | $-2.87 | 37.32% |
| 2021 | $-2.09 | 111.11% |
| 2020 | $-0.99 | 6.45% |
| 2019 | $-0.93 | 93.75% |
| 2018 | $-0.48 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | -632.92% |
US
|
|
| $-7.98 | 145.54% |
US
|
|
| $-5.29 | 62.77% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -953.54% |
NL
|
